TKNO FY 2022 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$133M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$41M+12.3% YoY

Gross Profit

$17M42.2% margin

Operating Income

-$50M-119.9% margin

Net Income

-$47M-114.6% margin

EPS (Diluted)

$-1.69

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$56M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$152M

Total Liabilities

$52M

Stockholders' Equity

$100M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$37M	+12.3%
Gross Profit	$17M	$18M	-0.8%
Operating Income	-$50M	-$12M	-313.5%
Net Income	-$47M	-$10M	-384.2%